Neal James R 4/A
4/A · Processa Pharmaceuticals, Inc. · Filed Sep 18, 2025
Insider Transaction Report
Form 4/AAmended
Neal James R
Director
Transactions
- Award
Restricted Stock
2024-09-03+31,206→ 36,275 totalExercise: $0.00→ Common Stock (31,206 underlying)
Footnotes (2)
- [F1]The restricted stock vest on the earlier of June 28, 2025 or the next annual meeting of stockholders, subject to certain distribution requirements.
- [F2]Amending to correct the beneficially owned shares reported on the Form 4 filed September 18, 2024.